[Federal Register Volume 67, Number 101 (Friday, May 24, 2002)]
[Notices]
[Page 36577]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-13045]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, or Partially Exclusive Licensing 
of U.S. Patent Application Concerning Antibodies Against Type A 
Botulinum Neurotoxin

AGENCY: Department of the Army, DOD

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is 
made of the availability for licensing of U.S. Patent Application No. 
09/465,276 entitled ``Antibodies Against Type A Botulinum Neurotoxin,'' 
filed December 16, 1999. The United States Government, as represented 
by the Secretary of the Army has rights in this invention.

ADDRESSES: Commander, U.S. army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Antibodies for binding epitopes of BoNT/A 
and hybridomas which produce such antibodies are described. The 
antibodies of the present invention can be used in a method for 
detecting BoNT/A in a sample and/or in a method for purifying BoNT/A 
from an impure solution. In addition, the antibodies can to be used for 
passive immunization against BoNT/A intoxication or as intoxication 
therapy. Another aspect of the invention is a kit for detecting BoNT/A 
in a sample.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 02-13045 Filed 5-23-02; 8:45 am]
BILLING CODE 3710-08-M